Cawello W - Search Results

1

Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.

Cawello W, Mueller-Voessing C, Andreas JO. Cawello W, et al. Clin Drug Investig. 2014 May;34(5):327-34. doi: 10.1007/s40261-014-0180-7. Clin Drug Investig. 2014. PMID: 24634110 Clinical Trial.

2

Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies.

Elshoff JP, Braun M, Andreas JO, Middle M, Cawello W. Elshoff JP, et al. Among authors: cawello w. Clin Ther. 2012 Apr;34(4):966-78. doi: 10.1016/j.clinthera.2012.02.008. Epub 2012 Mar 7. Clin Ther. 2012. PMID: 22401642 Clinical Trial.

3

Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment.

Cawello W, Bökens H, Nickel B, Andreas JO, Halabi A. Cawello W, et al. Epilepsia. 2013 Jan;54(1):81-8. doi: 10.1111/j.1528-1167.2012.03725.x. Epub 2012 Nov 13. Epilepsia. 2013. PMID: 23148731 Free article. Clinical Trial.

4

Pharmacokinetics of lacosamide and omeprazole coadministration in healthy volunteers: results from a phase I, randomized, crossover trial.

Cawello W, Mueller-Voessing C, Fichtner A. Cawello W, et al. Clin Drug Investig. 2014 May;34(5):317-25. doi: 10.1007/s40261-014-0177-2. Clin Drug Investig. 2014. PMID: 24567279 Clinical Trial.

5

Advances in epilepsy treatment: lacosamide pharmacokinetic profile.

Cawello W, Stockis A, Andreas JO, Dimova S. Cawello W, et al. Ann N Y Acad Sci. 2014 Nov;1329:18-32. doi: 10.1111/nyas.12513. Epub 2014 Aug 28. Ann N Y Acad Sci. 2014. PMID: 25167889 Review.

6

No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotine.

Elshoff JP, Cawello W, Andreas JO, Braun M. Elshoff JP, et al. Among authors: cawello w. Clin Pharmacol Drug Dev. 2014 May;3(3):187-93. doi: 10.1002/cpdd.78. Epub 2014 Feb 12. Clin Pharmacol Drug Dev. 2014. PMID: 27128608

7

Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopa.

Braun M, Cawello W, Andreas JO, Boekens H, Horstmann R. Braun M, et al. Among authors: cawello w. J Clin Pharmacol. 2009 Sep;49(9):1047-55. doi: 10.1177/0091270009338481. Epub 2009 Jul 23. J Clin Pharmacol. 2009. PMID: 19628729 Clinical Trial.

8

Effect of age and sex on lacosamide pharmacokinetics in healthy adult subjects and adults with focal epilepsy.

Schaefer C, Cawello W, Waitzinger J, Elshoff JP. Schaefer C, et al. Among authors: cawello w. Clin Drug Investig. 2015 Apr;35(4):255-65. doi: 10.1007/s40261-015-0277-7. Clin Drug Investig. 2015. PMID: 25708532

9

Pharmacokinetic properties and tolerability of rotigotine transdermal patch after repeated-dose application in healthy korean volunteers.

Kim BH, Yu KS, Jang IJ, Soo Lim K, Kim JR, Elshoff JP, Andreas JO, Braun M, Cawello W. Kim BH, et al. Among authors: cawello w. Clin Ther. 2015 Apr 1;37(4):902-12. doi: 10.1016/j.clinthera.2015.01.013. Epub 2015 Mar 16. Clin Ther. 2015. PMID: 25791613 Clinical Trial.

10

An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome.

Elshoff JP, Cawello W, Andreas JO, Mathy FX, Braun M. Elshoff JP, et al. Among authors: cawello w. Drugs. 2015 Apr;75(5):487-501. doi: 10.1007/s40265-015-0377-y. Drugs. 2015. PMID: 25795100 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters